Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response
about
Second-site mutations selected in transcriptional regulatory sequences compensate for engineered mutations in the vesicular stomatitis virus nucleocapsid proteinSelection for gene junction sequences important for VSV transcriptionModel-based design of growth-attenuated virusesNeurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development.A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice.Gene order rearrangement of the M gene in the rabies virus leads to slower replication.Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneRecombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positionsSecond-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenicSynergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectorsDirected Fusion of Mesenchymal Stem Cells with Cardiomyocytes via VSV-G Facilitates Stem Cell Programming.Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in miceGeneration of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.Fitness analyses of vesicular stomatitis strains with rearranged genomes reveal replicative disadvantages.Identification of viral genomic elements responsible for rabies virus neuroinvasiveness.Phenotypic Consequences In vivo and In vitro of Rearranging the P Gene of RABV HEP-Flury.Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivityReverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development.Vesicular stomatitis viruses with rearranged genomes have altered invasiveness and neuropathogenesis in mice.Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host.Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.Characterization of recombinant rabies virus carrying double glycoprotein genes.Attenuated Infectious Hematopoietic Necrosis Virus with Rearranged Gene Order as Potential Vaccine.Theory of lethal mutagenesis for viruses.Reverse Genetics of Rhabdoviruses
P2860
Q30421666-2B04E3B2-9544-4E0A-8BBE-6CB5CB83A41EQ30438147-098C1414-7019-44AA-AE3B-5F30B77B973AQ33256104-15551A50-E525-4F7C-B971-5076F8DEA8C2Q33743852-48FD06EE-51FF-45BE-9133-3379AA3568BEQ33842546-F00FB05C-EDB1-4CD6-88D9-17F03FAA98A9Q34172295-F3833CF6-1B16-43C0-8FC2-67955404D022Q34300058-A99F1BB2-C6EA-47FF-A337-319B7988ABE7Q34328895-A1C55E21-0C86-4FBD-A801-36063BBDC6EDQ34359826-E1000BAD-4B2A-4DB4-A423-9C510CEB1820Q34461764-3C64D6C5-21F0-4D66-ADA9-DFE574DF50A4Q35635393-0C0AE3C2-3F45-40E9-A4A5-D4370353D54DQ35760520-50F1B83E-85FB-421D-923E-CDD975315F2DQ36014854-63D43FD3-A4A1-440B-A324-74CC9C7C5F77Q36043290-45F14D40-FB96-427A-AAF7-6C11FAFC255FQ36611663-BEF67D79-FE66-4DD6-9622-722AE3A1D7B3Q37069798-4483A3D9-2ACE-4AA2-8677-2AF3D0FFC037Q37492459-F90A4FBA-502D-4082-8D81-2FA3E0446567Q37621776-B81DEDEE-95DB-495E-A929-046F8830D178Q37622046-5EBBE0E9-CCE4-4E5A-BAC5-687E97A7027FQ38940832-BF5B5D6B-E726-4A93-9534-16F5CFE06940Q39004337-09643106-A501-4B00-87FF-59783BD84E58Q39748967-17BCB2EA-B31F-4A36-BC78-2A1611DC54F0Q39776525-A0208599-C3B7-4D7D-BEAB-F2869F8540CBQ40156113-3FB59563-1C63-493E-87FE-AE41EEE4969CQ40302342-22B2B409-887F-4D47-B7C9-D530D97BB494Q40524625-C7F19C71-CBF5-4E5B-8134-8AC3AE3A42A5Q41979840-E0AA19C3-B326-4B69-872D-BF420F53B42AQ57077874-6E84ED0F-DAA3-4771-BE84-AFE700E4BDA1
P2860
Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Moving the glycoprotein gene o ...... the protective immune response
@en
Moving the glycoprotein gene o ...... he protective immune response.
@nl
type
label
Moving the glycoprotein gene o ...... the protective immune response
@en
Moving the glycoprotein gene o ...... he protective immune response.
@nl
prefLabel
Moving the glycoprotein gene o ...... the protective immune response
@en
Moving the glycoprotein gene o ...... he protective immune response.
@nl
P2093
P2860
P1433
P1476
Moving the glycoprotein gene o ...... the protective immune response
@en
P2093
P2860
P304
P356
10.1128/JVI.74.17.7895-7902.2000
P407
P577
2000-09-01T00:00:00Z